Shanghai Yizhong Pharmaceutical Co Ltd (688091) — Free Cash Flow Generation Index

Latest as of September 2025: -0.44x

Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Free Cash Flow Generation Index of -0.44x as of September 2025. Free cash flow of CN¥-9.33 Million represents 0% of operating cash flow (CN¥21.03 Million). Explore Shanghai Yizhong Pharmaceutical Co Ltd (688091) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

-0.44x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥-9.33 Million
CNY

Operating Cash Flow

CN¥21.03 Million
CNY

Capital Expenditures

CN¥30.36 Million
CNY

Shanghai Yizhong Pharmaceutical Co Ltd Free Cash Flow Generation Index (2022–2024)

Historical FCF Generation Index trend for Shanghai Yizhong Pharmaceutical Co Ltd across 3 annual periods. For the full cash flow conversion analysis, see 688091 operating cash flow.

Annual Free Cash Flow Generation for Shanghai Yizhong Pharmaceutical Co Ltd (2022–2024)

Year-by-year Free Cash Flow Generation Index for Shanghai Yizhong Pharmaceutical Co Ltd. Check 688091 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2024 -1.03x CN¥-40.60 Million CN¥39.44 Million CN¥80.04 Million ▼ -214.6%
2023 0.90x CN¥77.77 Million CN¥86.55 Million CN¥8.78 Million ▲ +32.9%
2022 0.68x CN¥74.90 Million CN¥110.78 Million CN¥35.88 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).